Recombinant factor VIIa to correct coagulopathy in patients with traumatic brain injury presenting to outlying facilities before transfer to the regional trauma center

American Surgeon

Volumn 78, Issue 1, 2012, Pages 57-60

  Brown, Carlos V R ^a   Sowery, Lauren ^a   Curry, Eardie ^a   Valadka, Alex B ^a   Glover, Cynthia S ^b   Kim, Grabarkewitz ^c   Green, Terry ^d   Hail, Steve ^e   Admire, John ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b Seton Highland Lakes Medical Center   (United States)

^c Seton Edgar B Davis Hospital   (United States)

^d Seton Southwest Healthcare Center   (United States)

^e Seton Medical Center Austin   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; WARFARIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD CLOTTING DISORDER; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FALLING; FEMALE; GLASGOW COMA SCALE; HUMAN; INJURY SEVERITY; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; MALE; OUTCOME ASSESSMENT; PATIENT TRANSPORT; RETROSPECTIVE STUDY; SEX DIFFERENCE; SINGLE DRUG DOSE; TRAUMATIC BRAIN INJURY; TREATMENT DURATION;

AGED; BLOOD COAGULATION DISORDERS; BRAIN INJURIES; CHI-SQUARE DISTRIBUTION; FACTOR VIIA; FEMALE; GLASGOW COMA SCALE; HUMANS; INJURY SEVERITY SCORE; INTERNATIONAL NORMALIZED RATIO; MALE; PATIENT TRANSFER; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; TRAUMA CENTERS; TREATMENT OUTCOME;

EID: 84857081758     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Meyer J. Age: 2000, Census 2000 Brief.Washington DC: US Census Bureau, 2001. Available at: http://www.census.gov/prod/ 2001pubs/c2kbr01-12.pdf. Accessed November 17, 2009.
2. Lavoie A, Ratte S, Clas D. Preinjury warfarin use among elderly patients with closed head injuries in a trauma center. J Trauma 2004;56:802-7. (Pubitemid 38534091)
3. Cohen DB, Rinker C, Wilberger JE. Traumatic brain injury in anticoagulated patients. J Trauma 2006;60:553-7.
4. Ivascu FA, Howells GA, Junn FS, et al. Rapid warfarin reversal in anticoagulated patients with traumatic intracranial hemorrhage reduces hemorrhage progression and mortality. J Trauma 2005;59:1131-9. (Pubitemid 43060969)
5. Bartal C, Freedman J, Bowman K, et al. Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa. J Trauma 2007;63:725-32. (Pubitemid 350287285)
6. Stein DM, Dutton RP, Kramer ME, et al. Recombinant factor VIIa: decreasing time to intervention in coagulopathic patients with severe traumatic brain injury. J Trauma 2008;64:620-8.
7. Stein DM, Dutton RP, Kramer ME, et al. Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. J Trauma 2009;66:63-75.
8. Narayan RK, Maas AIR, Marshall LF, et al. Recombinant factor VIIa in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial. Neurosurgery 2008;62:776-88.
9. Brown CVR, Foulkrod KH, Lopez D, et al. Recombinant Factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma patients. J Trauma 2010;68: 348-52.